These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 28963352)
21. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease. Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988 [TBL] [Abstract][Full Text] [Related]
22. mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer. Liang SQ; Bührer ED; Berezowska S; Marti TM; Xu D; Froment L; Yang H; Hall SRR; Vassella E; Yang Z; Kocher GJ; Amrein MA; Riether C; Ochsenbein AF; Schmid RA; Peng RW Oncogene; 2019 Jan; 38(5):622-636. PubMed ID: 30171261 [TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitors reduce WB-F344 oval cell viability and migration capability by suppressing AKT/mTOR signaling in vitro. Zhang P; Zhu X; Wu Y; Hu R; Li D; Du J; Jiao X; He X Arch Biochem Biophys; 2016 Jan; 590():1-9. PubMed ID: 26558695 [TBL] [Abstract][Full Text] [Related]
24. Mechanistic target of rapamycin (mTOR) dependent regulation of thioredoxin interacting protein (TXNIP) transcription in hypoxia. Wong RW; Hagen T Biochem Biophys Res Commun; 2013 Mar; 433(1):40-6. PubMed ID: 23454121 [TBL] [Abstract][Full Text] [Related]
25. TXNIP/Redd1 signalling and excessive autophagy: a novel mechanism of myocardial ischaemia/reperfusion injury in mice. Gao C; Wang R; Li B; Guo Y; Yin T; Xia Y; Zhang F; Lian K; Liu Y; Wang H; Zhang L; Gao E; Yan W; Tao L Cardiovasc Res; 2020 Mar; 116(3):645-657. PubMed ID: 31241142 [TBL] [Abstract][Full Text] [Related]
26. RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers. Nichols RJ; Haderk F; Stahlhut C; Schulze CJ; Hemmati G; Wildes D; Tzitzilonis C; Mordec K; Marquez A; Romero J; Hsieh T; Zaman A; Olivas V; McCoach C; Blakely CM; Wang Z; Kiss G; Koltun ES; Gill AL; Singh M; Goldsmith MA; Smith JAM; Bivona TG Nat Cell Biol; 2018 Sep; 20(9):1064-1073. PubMed ID: 30104724 [TBL] [Abstract][Full Text] [Related]
29. Age-related changes in mitochondrial antioxidant enzyme Trx2 and TXNIP-Trx2-ASK1 signal pathways in the auditory cortex of a mimetic aging rat model: changes to Trx2 in the auditory cortex. Sun HY; Hu YJ; Zhao XY; Zhong Y; Zeng LL; Chen XB; Yuan J; Wu J; Sun Y; Kong W; Kong WJ FEBS J; 2015 Jul; 282(14):2758-74. PubMed ID: 25996168 [TBL] [Abstract][Full Text] [Related]
30. MondoA-Mlx transcriptional activity is limited by mTOR-MondoA interaction. Kaadige MR; Yang J; Wilde BR; Ayer DE Mol Cell Biol; 2015 Jan; 35(1):101-10. PubMed ID: 25332233 [TBL] [Abstract][Full Text] [Related]
31. Induction of Thioredoxin-Interacting Protein by a Histone Deacetylase Inhibitor, Entinostat, Is Associated with DNA Damage and Apoptosis in Esophageal Adenocarcinoma. Feingold PL; Surman DR; Brown K; Xu Y; McDuffie LA; Shukla V; Reardon ES; Crooks DR; Trepel JB; Lee S; Lee MJ; Gao S; Xi S; McLoughlin KC; Diggs LP; Beer DG; Nancarrow DJ; Neckers LM; Davis JL; Hoang CD; Hernandez JM; Schrump DS; Ripley RT Mol Cancer Ther; 2018 Sep; 17(9):2013-2023. PubMed ID: 29934340 [TBL] [Abstract][Full Text] [Related]
32. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. Mayo MW; Denlinger CE; Broad RM; Yeung F; Reilly ET; Shi Y; Jones DR J Biol Chem; 2003 May; 278(21):18980-9. PubMed ID: 12649266 [TBL] [Abstract][Full Text] [Related]
33. TORC1 is essential for NF1-associated malignancies. Johannessen CM; Johnson BW; Williams SM; Chan AW; Reczek EE; Lynch RC; Rioth MJ; McClatchey A; Ryeom S; Cichowski K Curr Biol; 2008 Jan; 18(1):56-62. PubMed ID: 18164202 [TBL] [Abstract][Full Text] [Related]
34. Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9-coupled Affinity Purification/Mass Spectrometry Analysis Revealed a Novel Role of Neurofibromin in mTOR Signaling. Li X; Gao M; Choi JM; Kim BJ; Zhou MT; Chen Z; Jain AN; Jung SY; Yuan J; Wang W; Wang Y; Chen J Mol Cell Proteomics; 2017 Apr; 16(4):594-607. PubMed ID: 28174230 [TBL] [Abstract][Full Text] [Related]
35. Palmitate and insulin counteract glucose-induced thioredoxin interacting protein (TXNIP) expression in insulin secreting cells via distinct mechanisms. Panse M; Kluth O; Lorza-Gil E; Kaiser G; Mühlbauer E; Schürmann A; Häring HU; Ullrich S; Gerst F PLoS One; 2018; 13(5):e0198016. PubMed ID: 29813102 [TBL] [Abstract][Full Text] [Related]
36. All-trans retinoic acid ameliorates hepatic stellate cell activation via suppression of thioredoxin interacting protein expression. Shimizu H; Tsubota T; Kanki K; Shiota G J Cell Physiol; 2018 Jan; 233(1):607-616. PubMed ID: 28322443 [TBL] [Abstract][Full Text] [Related]
37. Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells. Makarević J; Tawanaie N; Juengel E; Reiter M; Mani J; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA J Cell Mol Med; 2014 Jul; 18(7):1460-6. PubMed ID: 24779401 [TBL] [Abstract][Full Text] [Related]
38. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells. Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608 [TBL] [Abstract][Full Text] [Related]
39. Histone acetylation of glucose-induced thioredoxin-interacting protein gene expression in pancreatic islets. Bompada P; Atac D; Luan C; Andersson R; Omella JD; Laakso EO; Wright J; Groop L; De Marinis Y Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):82-91. PubMed ID: 27989964 [TBL] [Abstract][Full Text] [Related]
40. The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens. Wu YY; Wu HC; Wu JE; Huang KY; Yang SC; Chen SX; Tsao CJ; Hsu KF; Chen YL; Hong TM J Exp Clin Cancer Res; 2019 Jul; 38(1):282. PubMed ID: 31262325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]